Please login to the form below

Not currently logged in
Email:
Password:

Chiltern appoints Roger Hunter to partnerships role

He will be tasked with developing long-term strategic partnerships

Chiltern Roger HunterUK-headquartered contract research organisation (CRO) has appointed Roger Hunter as vice president of strategic partnerships within its business development team.

He brings 25 years of pharma and biotech experience to the company and his most recent industry-side role was as VP of operations for a speciality pharmaceutical company.

Chiltern's VP of global business development Stuart McGuire said: “It gives me great pleasure to welcome Roger Hunter as Chiltern's new VP of strategic partnerships. Roger comes to us with a strong background in both commercial and development functions within pharma and biotech. He has a strong understanding of clinical development and a deep appreciation of the impact that we have on our clients.”

Roger Hunter added: “I look forward to working in close collaboration with our sponsors to develop long standing strategic partnerships with them through the delivery of innovative, quality and flexible solutions that address their key needs.” 

16th January 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics